ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 161 filers reported holding ARCUS BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $270 | -17.7% | 15,038 | -6.8% | 0.02% | -19.2% |
| Q2 2023 | $328 | -23.0% | 16,136 | -30.9% | 0.03% | -16.1% |
| Q1 2023 | $426 | +101.9% | 23,335 | +128.5% | 0.03% | +72.2% |
| Q4 2022 | $211 | -99.9% | 10,214 | -35.0% | 0.02% | -52.6% |
| Q3 2022 | $411,000 | -8.7% | 15,720 | -11.6% | 0.04% | -7.3% |
| Q2 2022 | $450,000 | +75.8% | 17,775 | +119.3% | 0.04% | +412.5% |
| Q1 2022 | $256,000 | – | 8,105 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $50,877,000 | 22.64% |
| Octagon Capital Advisors LP | 2,489,974 | $78,584,000 | 16.99% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $27,451,000 | 8.41% |
| BVF INC/IL | 3,960,948 | $125,008,000 | 5.00% |
| PFM Health Sciences, LP | 3,431,010 | $108,283,000 | 4.05% |
| EcoR1 Capital, LLC | 3,265,101 | $103,047,000 | 3.22% |
| Alphabet Inc. | 2,563,441 | $80,902,000 | 2.62% |
| Boxer Capital, LLC | 1,432,200 | $45,200,000 | 2.32% |
| SECTORAL ASSET MANAGEMENT INC | 338,480 | $10,682,000 | 1.90% |
| PARK CIRCLE Co | 64,000 | $2,020,000 | 1.68% |